Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 5c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Reading (RDI) Tops Q2 EPS by 4c